Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06019767 · ClinicalTrials.gov registry record · NA

Peer-led Trauma Therapy for Re-entry

A NA study of PTSD, sponsored by University of Wisconsin, Madison.

Completed
Registry status
NA
Development phase
59
Enrollment target
1
Study location

NCT06019767 is a NA study of PTSD that has completed, run by University of Wisconsin, Madison. The registered enrollment target is 59 participants, below the 302-participant average among 154 other PTSD trials with a reported enrollment target (80% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06019767, a NA study of PTSD, has completed, sponsored by University of Wisconsin, Madison.

COMPLETED
Registry status
NA
Development phase
59 participants
Enrollment target
1
Study location

Study Summary

The purpose of the research is to learn more about how to treat PTSD for people directly impacted by incarceration (i.e., have spent time in prison or jail). This research will help identify if a PTSD treatment group that is used in community settings, and led by individuals with lived experience, is helpful in reducing PTSD symptoms among people who have been directly impacted by incarceration. Participants will complete an interview to determine whether they are experiencing PTSD, and if so, will participate in a 6-week therapy group treatment.

Conditions Studied

Interventions

  • BEHAVIORAL Cognitive Processing Therapy

Study Locations (1)

Wisconsin

  • University of Wisconsin - Madison

Trial Details

FieldValue
Enrollment Target 59 participants
Start Date 2023-11-14
Est. Completion 2025-12-12
Phase NA

Sponsor

University of Wisconsin, Madison

1,039 total trials

What the Registry Record Tells You About NCT06019767

The ClinicalTrials.gov registry entry for NCT06019767 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 59 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 302-participant average among 154 other PTSD trials with a reported enrollment target (80% lower). The listed sponsor is University of Wisconsin, Madison, which has 1,039 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with PTSD appearing as the primary indexed condition, and to 1 intervention - of which Cognitive Processing Therapy is the first listed.

NCT06019767 reports 1 study location spanning 1 distinct geographic area - top geographies include Wisconsin.

Frequently Asked Questions

What is clinical trial NCT06019767 about?

NCT06019767 is a clinical study titled "Peer-led Trauma Therapy for Re-entry". The purpose of the research is to learn more about how to treat PTSD for people directly impacted by incarceration (i.e., have spent time in prison or jail). This research will help identify if a PTSD treatment group that is used in community settings, and led by individuals with lived experience, i...

What is the current status of trial NCT06019767?

This trial is currently completed. It is a NA study. The enrollment target is 59 participants. The study started on 2023-11-14. Estimated completion is 2025-12-12.

What conditions does trial NCT06019767 study?

This clinical trial studies the following conditions: PTSD.

What interventions are being tested in trial NCT06019767?

The interventions under investigation include: Cognitive Processing Therapy (BEHAVIORAL).

Who is sponsoring clinical trial NCT06019767?

This trial is sponsored by University of Wisconsin, Madison, which has 1,039 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06019767 being conducted?

This trial has 1 study location across Wisconsin. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for PTSD

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.